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A B S T R A C T
The chemokine receptor 2 (CCR2) was first described as a chemotactic factor involved in immune responses, but
it also plays an essential function in several biological processes. The chemokine (C–C motif) ligand 2 (CCL2)
binds to CCR2 triggering G protein-coupled receptor (GPCR) signaling in leukocytes, including activation of
PI3K/Akt/mTOR, a key pathway that is also related to follicular activation and survival. However, the potential
role of CCR2 in ovarian follicular physiology remain unexplored. Thus, we investigated the role of CCR2 on
follicular growth during adult life and aging. Ovaries and oocytes were collected from wild type (WT) mice at 1.5
months old (mo), and CCR2 expression was observed predominantly in oocytes included in growing follicles, as
well as after ovulation. Follicle populations were assessed in WT and CCR2-/- mice at 1.5 mo, and CCR2-/- mice
had more primordial and less primary and secondary follicles, while there were no differences in antral follicle
numbers. Pro-apoptotic genes Bax and Casp3 were downregulated, while anti-apoptotic Bcl2 was upregulated in
CCR2-/- mice. To further characterize the role of CCR2 in ovarian aging, follicle populations were assessed in WT
and CCR2-/- mice at 1.5, 2.5, 6, 10, and 12 mo. A larger ovarian follicular reserve at 1.5–6 mo was observed in
CCR2-/- mice. Finally, CCR2-/- aged mice (6–12 mo) ovulated more oocytes than WT mice. Altogether, these
data suggest that CCR2 plays an important role in the regulation of murine folliculogenesis, potentially affecting
the reproductive lifespan.
1. Introduction
In most mammals, the ovarian follicular reserve is established
during embryogenesis and gradually decreases throughout prepubertal
and adult life (Monniaux et al., 2014; Goldman et al., 2017; Ye et al.,
2019). Regularly, some of the primordial follicles are activated and
develop into growing follicles, which are classified as primary, sec-
ondary, or antral follicles, according to their morpho-functional aspects
(Campos-Junior et al., 2012a; Monniaux et al., 2014). The size of the
ovarian reserve, as well as the rates of follicular mobilization and
atresia, are the main determinants of the ovarian functional lifespan. A
major mechanism responsible for low follicle counts associated with
aging is atresia, which is triggered by apoptosis, regulated by activation
of pro- or anti-apoptotic genes (Uri-Belapolsky et al., 2014). In that
regard, unraveling the mechanism that regulates follicular survival is
critical to prevent female infertility (Hsueh et al., 2015; Shen et al.,
2019).
The molecular mechanisms that drive follicle activation are still
poorly understood. Follicle activation is likely to be regulated by highly
controlled pathways to ensure a sustainable balance between quies-
cence and growth, preventing premature exhaustion of the ovarian
reserve (Uri-Belapolsky et al., 2014). Among the potential regulatory
mechanisms, a critical role of the PI3K/Akt/mTOR signaling pathway
has been proposed (Monniaux et al., 2014; Hsueh et al., 2015; Novella-
Maestre et al., 2015; Goldman et al., 2017; Grosbois and Demeestere,
2018; Zhang et al., 2019). The incubation of ovarian tissue with PI3K
activators, such as 740Y-P, leads to a substantial primordial follicle
activation (Grosbois and Demeestere, 2018).
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Chemokines and chemokine receptors form a complex and diverse
system relevant to the physiology of the immune system, including
leukocyte activation and cell trafficking (Russo et al., 2010). The pro-
duction of chemokines also occurs physiologically under tissue home-
ostasis but may be induced by stress associated with inflammatory
stimulus such as infectious diseases and cancer (Russo, 2010). The
chemokine (C–C motif) ligand 2 (CCL2) and its receptor chemokine
(C–C motif) receptor 2 (CCR2) play important roles in the immune
response, such as macrophage chemotaxis, tissue inflammation, tumor
invasion, and metastasis (Russo et al., 2010; Castela et al., 2017; Yang
et al., 2018). It is well known that CCL2−CCR2 interaction activates
the PI3K/Akt/mTOR signaling pathway in several cell types, including
leukocytes (Russo et al., 2010; Yang et al., 2018). Previous studies re-
ported the expression of CCR2 in the theca and perifollicular stroma of
human preovulatory follicles (Dahm-Kähler et al., 2009) and in the
cumulus-oocyte complexes and follicular wall in feline ovaries (Rojo
et al., 2019). It was also over-expressed in the ovaries of obese rats
(Ruebel et al., 2016), however, the role of CCR2 in the context of
murine ovarian follicular physiology is not fully understood. We hy-
pothesized that CCL2−CCR2 may be enrolled in follicular mobilization
and thus affect fertility lifespan in vivo. To explore this, we evaluated
the CCR2 expression in mice ovaries, as well as the impact of CCR2
deficiency on follicular mobilization during adult life and mice aging.
2. Materials and methods
2.1. Animals and facilities
Female mice C57BL/6 (wild type - WT, n = 74) and B6.129S4-
Ccr2tm1Ifc/J CCR2-/-; (Boring et al., 1997; Russo et al., 2018; n = 68)
used in this study were obtained from the Universidade Federal de
Minas Gerais and maintained in a positive pressure room isolated from
other animals. Cages were filter-topped, and mice had free access to
sterilized food and water. The daily light cycle was 12/12 h (light/
dark). Animals were inspected daily and, when required, euthanasia
was performed using high sedative doses (15.8 mg/kg xylazine and
139.6 mg/kg ketamine). Body and ovarian weight from all animals used
in this study were measured, and gonad somatic index (GSI - ovarian
mass divided by body weight × 100) also was calculated. The number
of puppies per litter and litters from homozygous couples (WT♂ x
WT♀ and CCR2-/-♂ x CCR2-/-♀) were recorded during a one-year
interval and analyzed. Additionally, the stage of estrous cycle were
evaluated by vaginal cytology (Byers et al., 2012) daily, during 2
months, starting at 1.5 mo, and its length was obtained and compared.
This study was approved by the Institutional Animal Care and Use
Committee of the Universidade Federal University de São João del Rei
(Protocol number 27/14 CEUA/FUSJ).
2.2. Experimental design
To immunolocalize CCR2 on ovarian parenchyma, ovaries of WT (n
= 3) at 1.5 months old (mo) were collected and processed for im-
munoperoxidase and immunofluorescence. CCR2 immunolocalization
on oocytes was evaluated by immunofluorescence using WT mice (n =
3), at the same age. CCR2 protein detection on ovarian parenchyma was
performed by Western Blot, using total protein lysates from WT (n = 4)
and CCR2-/- (n = 4) mice.
Ovarian histology was used to address potential differences in fol-
licle population numbers, that were compared in 1.5 mo WT and
CCR2-/- mice (n = 6 and 6, respectively). In order to evaluate the
follicular mobilization during aging, histological follicle quantification
was performed in WT and CCR2-/- mice at the following ages: 1.5, 2.5,
6, 10, and 12 mo (n = 6 per age and group, total n = 60) mo, only
ovaries derived from females on proestrus were used, as determined by
vaginal cytology (Byers et al., 2012). Oocyte collection was performed
in another group of WT and CCR2-/- mice, at the same ages (1.5, 2.5, 6,
10, and 12 mo; n = 6 per age and group, total n = 60). Finally,
quantitative Real Time PCR, was performed in WT (n = 4) and CCR2-/-
(n = 4) to evaluate the expression of genes related to follicular atresia
and growth.
2.3. Immunostaining
Ovaries were collected from WT and CCR2-/- at 1.5 mo, fixed in 4%
(wt/vol) paraformaldehyde (PFA; Ref. 30525−89-4, Sigma-Aldrich, St.
Louis, MO, USA), and embedded in paraffin (Sigma-Aldrich, 327204, St.
Louis, MO, USA). Ovarian sections (5 μm) were dewaxed and rehy-
drated, antigen retrieval was performed in citrate buffer (pH 6.0) for 5
min after boiling in a microwave oven for approximately 10 min.
Nonspecific background was blocked for 5 min with Ultra-V-Block
(Thermo Scientific, TA-060-UB, Waltham, MA, USA) incubation at
room temperature. Tissue sections were then incubated overnight at 4
°C with primary antibody anti−CCR2 antibody [EPR19698] (Abcam,
ab222496, Cambridge, UK) at 1:200. Antigens were detected by in-
cubation with Alexa Fluor 488 donkey anti-rabbit IgGA21206 [1:500]
(Abcam, Cambridge, UK); for 1 h at room temperature. After nuclear
counterstaining using 4′,6-diamidino-2-phenylindole (Sigma-Aldrich;
D8417−1MG St. Louis, MO, USA), sections were mounted with Mowiol
4–88 solution (Merck; 475904, Frankfurther, Darmstadr, Germany). To
evaluate the expression of CCR2 on metaphase II (MII) oocytes, these
structures were recovered from WT and CCR2-/- oviducts after gona-
dotropin stimulation (Campos-Junior et al., 2011). MII oocytes were
denuded, fixed in 4% of PFA (Ref. 30525−89-4, Sigma-Aldrich, St.
Louis, MO, USA), and incubated with primary and secondary antibody
as previously mentioned. Negative controls were performed in the ab-
sence of primary antibody.
For immunoperoxidase, ovaries were collected from WT and
CCR2-/- (1.5 mo), fixed in 4% (wt/vol) PFA (Ref. 30525−89-4, Sigma-
Aldrich, St. Louis, MO, USA), and embedded in paraffin. Ovarian sec-
tions (5 μm) were dewaxed and rehydrated, antigen retrieval was
performed in citrate buffer (pH 6.0) for 5 min after boiling in a mi-
crowave oven for approximately 10 min. Endogenous peroxidase was
quenched for 30 min with 3% H2O2 (Sigma-Aldrich; 216763, St. Louis,
MO, USA) in phosphate buffer solution (PBS; Ingamed, 216763,
Maringá, PR, Brazil). Nonspecific binding was blocked with Ultra-V-
Block. Primary antibody anti−CCR2 antibody [EPR19698] (ab222496)
at 1:200 was applied, and slides were incubated at 4 °C overnight.
Biotinylated anti-rabbit IgG (Abcam, Ab6721, Cambrigde, UK) antibody
(1:100) was applied and incubated for 60 min at room temperature.
Detection of the signal was performed by incubating in streptavidin
(TS-125-HR; Thermo Scientific, Waltham, MA, USA) for 10 min, fol-
lowed by reaction with peroxidase substrate diaminobenzidine (Sigma-
Aldrich; D8001, St. Louis, MO, USA) and counterstaining with hema-
toxylin (Merck; 105174, Frankfurther, Darmstadr, Germany) at room
temperature. Following dehydration, sections were mounted and ana-
lyzed. Negative controls were performed in the absence of primary
antibody.
To qualitatively evaluate the presence of CCR2 on mice ovaries,
western blot analysis was performed using total protein lysates from
WT and CCR2-/-. For this evaluation, total protein was isolated from
both ovaries of each animal. Protein extraction and western Blot were
performed as described by Campos-Junior et al., 2012b. Anti−CCR2
antibody [EPR19698] (Abcam, ab222496, Cambrigde, UK) at 1:200, or
Anti-beta Actin antibody (Abcam, ab8227, Cambrigde, UK) at 1:200
were used.
2.4. Histological evaluations and follicle quantification
Ovaries were collected from WT (n = 6) and CCR2-/- (n = 6) adult
female mice at 1.5 mo and fixed in PFA (Sigma-Aldrich, St. Louis, MO,
USA) solution. Paraffin-embedded ovaries were serially sectioned (5
μm) and stained with hematoxylin and eosin solution. In the third
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ovarian section, the number of primordial, primary, secondary, antral,
and atretic follicles were counted. Follicles were classified as previously
described (Campos-Junior et al., 2012a; Pereira et al., 2020) and fol-
licles (from primordial to antral) showing morphological signs of death
such as pyknosis, cellular fragmentation, and disintegration, were
classified as atretic. Only follicles containing an oocyte with a visible
nucleus were considered to avoid double-counting. Results are shown
as the number of counted follicles per ovary. Atresia rate (%) was de-
termined as the number of atretic follicles/total number of folli-
cles*100; and activation rate (%) as the number of growing follicles/
total number of follicles*100 (Campos-Junior et al., 2012a). Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL; Calbio-
chem, San Diego, CA, USA, Cat. No. QIA33) assay was performed, fol-
lowing the manufacturer's instructions, in paraffin sections (WT and
CCR2-/-) to in situ evaluation of follicle apoptosis. The percentage of
follicles containing TUNEL positive cells was evaluated in 10 sections
per mice in WT (n = 4) and CCR2-/- (n = 4).
2.5. Superovulation and oocyte collection
WT and CCR2-/- female mice at specific ages were primed with
gonadotropins as previously described (Campos-Junior et al., 2011).
Ovulated cumulus-oocyte complexes were isolated from the oviductal
ampullae into PBS 13 h after human chorionic gonadotropin adminis-
tration. Oocytes were denuded by a brief exposure to 400 IU/mL hya-
luronidase (Sigma-Aldrich; H3506, St. Louis, MO, USA) and counted.
2.6. qRT-PCR
Total RNA isolation was performed from WT and CCR2-/- ovaries
using RNeasy Mini kit (Qiagen GmbH,74104, Germantown, Maryland,
USA), according to the manufacturer’s instructions and samples were
treated with DNAse I (Qiagen GmbH, 15200−50, Germantown,
Maryland, USA) and primer sequences are depicted in Supplemental
Table 1. The gene expression pattern of the endogenous control (Gapdh)
was used as calibrators in order to calculate the differences in relative
abundance of transcripts between WT and CCR2-/-. Primer efficiency
was found as 2 and cycle threshold (Cts) among WT and CCR2-/-
samples were similar. Values are shown as n-fold difference. All pro-
cedures were performed as previously described by our group (Campos-
Junior et al., 2016; Pereira et al., 2020).
2.7. Statistical analyses
Data were tested for normality and homoscedasticity of variances.
Parametric data were evaluated by ANOVA and differences between
groups compared using the Student t-test. Non-parametric endpoints
were compared using the Wilcoxon test. All analyses were performed
using the GraphPad Prism (Version 5; GraphPad Software, Inc.). Results
are shown as mean± SD. A P value<0.05 was considered as sig-
nificant.
3. Results
3.1. CCR2 is expressed by oocytes included in growing follicles and ovulated
oocytes
CCR2 was observed by immunofluorescence in the oocytes (Fig. 1A)
from WT adult mice, and was not observed in the negative controls
(Fig. 1B). The immunoperoxidase also confirmed the expression of
CCR2 by WT oocytes at diverse developmental stages. CCR2 was ob-
served on growing oocytes included in primary, secondary, antral, or
atretic follicles (Fig. 1C–E). Interestingly, on dormant oocytes, included
in primordial follicles, CCR2 was not observed (Fig. 1C). There was no
staining for CCR2 on negative controls (Fig. 1F) as well as in CCR2-/-
ovarian samples (Fig. 1G-H).
We also evaluated the expression of CCR2 in MII oocytes recovered
from WT and CCR2-/- mice oviducts after in vivo superovulation pro-
tocol. Immunofluorescence confirmed the expression of CCR2 in MII
oocytes (Fig. 1I). Positive staining for CCR2 was observed neither on the
negative controls (Fig. 1J) nor in CCR2-/- (Fig. 1K).
3.2. CCR2 deficiency attenuates follicular activation and atresia
Body and ovarian weight, as well as GSI, were similar (p>0.05)
between WT and CCR2-/- mice (Sup. Fig. 1A–C). Western blot analyses
confirmed the presence of CCR2 protein on WT ovaries; on the other
hand, this protein was not detected on CCR2-/- ovaries. To validate
these analyses, B-actin was detected in both WT and CCR2-/- (Sup.
Fig. 1D, E). There was no difference (p>0.05) in the number of pup-
pies per litter between homozygous WT and CCR2-/- couples (Sup.
Fig. 2 A). However, CCR2-/- delivered less (p<0.05) litters in a one-
year interval (Sup. Fig. 2B), and showed longer estrous cycles
(p<0.05; Sup. Fig. 2C), compared to WT.
Histological analyses from a middle section of WT and CCR2-/-
ovaries indicated that both had a similar size (Fig. 2A,B). However, the
follicle counts showed that adult (1.5 mo) CCR2-/- mice had more
primordial follicles than WT mice (Fig. 2C). CCR2-/- mice also showed
less primary and secondary follicles (Fig. 2D), while there was no dif-
ference in the number of antral follicles when compared to WT mice
(Fig. 2D). Follicular activation and atresia rates were also quantified as
previously described (Campos-Junior et al., 2012a). The results in-
dicated lower follicular activation and atresia in CCR2-/- mice when
compared to WT mice (Fig. 2E,F).
3.3. CCR2 deficiency alters follicular atresia and the expression of genes
related to follicle survival
Morphologically, CCR2-/- mice showed (p<0.05) a reduced
number of atretic follicles compared to WT (Fig. 3A). These findings
were confirmed by the TUNEL assay (Fig. 3B-C), where follicles con-
taining TUNEL positive cells were less frequently (p<0.05) observed
in CCR2-/- mice at 1.5 mo (Fig. 3D). By real-time PCR, we found a pro-
survival balance of genes in ovaries of CCR2-/- mice. Pro-apoptotic
related genes Bax and Casp3 were downregulated in ovaries of CCR2-/-
mice when compared to WT (Fig. 3E), while the anti-apoptotic gene
Bcl2 was upregulated (Fig. 3E). Finally, there is no difference in the
expression of Fshr (a follicle growth marker) on CCR2-/- mice when
compared to WT mice (Fig. 3E).
3.4. CCR2 deficiency prolongs ovarian lifespan
Despite the observation that CCR2 deficiency attenuates follicular
activation at 1.5 mo when compared to WT mice, we further char-
acterized the ovarian lifespan during mice aging (1.5, 2.5, 6, 10, and 12
mo). Based on primordial follicle counts, we found a greater ovarian
follicular reserve in CCR2-/- mice at 1.5, 2.5, and 6 mo, but not at 10 or
12 mo, when compared to the WT mice (Fig. 4A). Finally, more oocytes
(p<0.05) were harvested after super stimulation of aged CCR2-/- mice
(6–12 mo), compared to the WT (Fig. 4B).
4. Discussion
The ovarian follicle reserve and the dynamics of follicular mobili-
zation, growth, and atresia are key components of female fertility, as
well as important predictors of the success of artificial reproductive
technologies. In this study, we investigated the role of the CC-chemo-
kine receptor 2 (CCR2) in ovarian physiology. The main findings were
that CCR2 was expressed in oocytes included in all classes of growing
follicles, as well as in MII oocytes, but not in primordial follicles. For the
first time, we showed that the lack of CCR2 resulted in reduced follicle
activation but also reduced follicle atresia, and thus prevented the early
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depletion of ovarian follicle reserves associated with aging. These re-
sults confirmed our hypothesis that CCR2 participates in the mechan-
isms that control the balance between follicle mobilization and atresia.
Previous studies have demonstrated that the PI3K/Akt/mTOR sig-
naling pathway leads to primordial follicle activation (Novella-Maestre
et al., 2015; Goldman et al., 2017; Grosbois and Demeestere, 2018). As
well, the CCL2 ligand activates CCR2 triggering this pathway in several
cell types (Yang et al., 2018), it was reasonable to hypothesize that
CCR2 could be part of the mechanism controlling follicular activation.
To confirm this, we first immunolocalized CCR2 in the ovary. The
presence of CCR2 in all classes of growing follicles suggests that the
expression of CCR2 could be a requirement for follicle activation and
growth. Interestingly, CCR2 was found in the oocytes, rather than in the
granulosa. It is well known that there is cross-talk between the oocyte
Fig. 1. Chemokine receptor 2 (CCR2) immunolocalization on
wild type (WT) and CCR2-/- mice ovaries and oocytes. (A)
CCR2 was immunolocalized in the oocyte of adult WT ovaries,
while (B) no staining was observed in negative controls. In a
more descriptive analysis using immunoperoxidase, CCR2
(C–E) was observed only in growing follicles: Primary (pr),
Secondary (s), Antral (an), and Atretic (at); on the other hand,
(C) CCR2 was not immunolocalized in Primordial (p) follicles.
(F) No staining was observed on WT negative control samples,
as well as on (G) CCR2-/- and (H) its negative control. (I) The
expression of CCR2 was also observed in ovulated MII oocytes,
but not in (J) negative control, or in (K) CCR2-/-. Bars A and B
=150 μm; C and D =100 μm; E - H =50 μm; I - K = 60 μm.
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and granulosa cells (Liu, 2007) and that the oocyte controls follicle
development through the production of paracrine factors such as
growth differentiation factor 9 (GDF9) and bone morphogenetic protein
(BMP15) (Sugiura et al., 2010). Our findings are coherent with the
active role of the oocyte in primordial follicle activation, supporting the
idea of the oocyte as “the conductor” of the transition from primordial
to primary follicles (van den Hurk and Zhao, 2005). The oocyte-specific
expression of CCR2 observed in the current study differs from that
observed in previous reports, in which this receptor was observed in
human and feline ovarian somatic cells (Dahm-Kähler et al., 2009; Rojo
et al., 2019). However, in these studies different antibodies and ex-
perimental models were used, and comparisons among these findings
requires caution.
Our results, using the CCR2 knockout mice, supported the hy-
pothesized importance of CCR2 in the control of follicle activation. The
lower follicular activation in CCR2-/- mice resulted in lower primary
and secondary follicle populations, and thus in a greater number of
primordial follicles. In this regard, the effects of the CCR2 deficiency
seem to be the opposite of those observed in the lack of the anti-
Mullerian hormone (AMH), another TGF-β family member involved in
the control of follicle activation. The AMH is also expressed only in
growing follicles, and its deficiency in mice does not impair fertility but
leads to precocious depletion of primordial follicle reserve (Durlinger
et al., 2002). It is noteworthy that the lack of CCR2 did not compromise
ovarian follicular reserve formation, somatic development, ovarian
size, or ovulatory capacity, suggesting that its action was through very
specific pathways and time windows. On the other hand, the main-
tenance of CCR2 expression in MII oocytes suggests that this receptor
may play roles in the reproductive process other than controlling fol-
licular development.
Interestingly, reduced follicular activation in CCR2-/- mice, and
consequent reduction in the populations of primary and secondary
follicles, did not affect the number of antral follicles. It was previously
demonstrated that mechanisms balancing activation and atresia re-
sulted in a similar number of antral follicles among mice strains with
different primordial follicle reserves (Campos-Junior et al., 2012a). In
the current study, we demonstrate that CCR2 acts in this mechanism.
The lower follicular activation in CCR2-/- mice was balanced by re-
duced follicular atresia, triggered by an upregulation of anti-apoptotic
(Bcl2) and a downregulation of pro-apoptotic (Bax, Casp3) genes and
confirmed by a reduced percentage of follicles containing TUNEL po-
sitive cells. The result was a similar antral follicle population when
compared to the WT mice, thus preserving the fertility of the CCR2-/-
mice. Coherently, there was no effect of CCR2 deficiency on Fshr
Fig. 2. The effects of CCR2 deficiency on adult mouse ovaries. A middle section of (A) WT and (B) CCR2-/- ovaries, showed CCR2 ablation does not affect ovarian
size. (C) In CCR2-/- ovaries was observed a greater number of primordial follicles (p<0.05), however numbers of (D) primary and secondary were lower in CCR2-/-
compared to WT (p<0.05), and the number of antral follicles was similar (p>0.05). (E, F) Rates of follicle activation and atresia were lower in CCR2-/- (p<0.05).
Bars = 4000 μm.
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expression, which has a key role in supporting antral follicle develop-
ment (Hillier, 2001).
Our results show that the lack of CCR2 in mice delayed the age-
related depletion of ovarian primordial follicle reserve, preserving the
capacity to respond to exogenous FSH hyperstimulation in older mice.
This is a very exciting finding, leading to the possible use of CCL2 or
CCR2 modulators (anti−CCL2 antibodies or CCR2 antagonists) as a
strategy to increase the female reproductive lifespan, particularly in
those conditions associated with precocious depletion of the ovarian
follicle reserve, such as with oncologic treatments. It was shown, for
example, that some drugs used in chemotherapy, such as cyclopho-
sphamide (Cy), causes ovarian depletion by activating the PI3K sig-
naling pathway and thus causing massive follicle activation, but this
effect could be counterbalanced by drugs or factors that downregulate
activation (Kalich-Philosoph et al., 2013; Sonigo et al., 2019). However,
potential side effects due to the participation of CCR2 in other several
biological processes, particularly related to the immune system (Yang
et al., 2018) must be considered. It is also to be determined if, and to
which extent, the maintenance of a greater ovarian reserve associated
with CCR2 deficiency also delays the progressive adverse effects of
aging on the follicular environment and oocyte quality (Krisher, 2019).
To the best of our knowledge, the present study is the first suggesting
that, in mice, CCR2 plays an important role in ovarian folliculogenesis,
potentially affecting the reproductive lifespan.
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Fig. 3. The effects of CCR2 deficiency on fol-
licular atresia and expression of genes related
to follicle survival and growth in adult mice.
(A) CCR2-/- mice showed a reduced (p<0.05)
number of atretic follicles compared to WT.
TUNEL staining revealed that (B) WT pre-
sented more apoptotic cells (arrowheads)
compared to (C) CCR2-/-, and this data was
quantitatively demonstrated, once in (D)
CCR2-/- ovaries a reduced (p<0.05) percen-
tage of follicles containing TUNEL positive
cells was observed. (E) Apoptotic markers Bax
and Caspase3 were downregulated in CCR2-/-
ovaries (p<0.05), while the anti-apoptotic
gene Bcl2 was downregulated (p<0.05).
There was no difference in the expression of
Fshr between CCR2-/- and WT ovaries
(p>0.05).
Fig. 4. The effects of CCR2 deficiency on ovarian aging. (A) CCR2-/- animals
showed a larger primordial follicle reserve from 1.5 to 6 mo compared to WT
(p<0.05), however, this difference was attenuated after 10 mo. Additionally,
(B) from 6 to 12 mo, CCR2-/- animals ovulated more MII oocytes compared to
WT (p<0.05) after exogenous stimulation.
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